Title
Category
Credits
Event date
Cost
Psychodynamic Psychopharmacology - David Mintz, MD (Recorded)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 APA
  • 1.00 ASWB-ACE
  • 1.00 Contact Hours/ Participation
$0.00
Psychodynamic Psychopharmacology is a psychodynamically-informed, patient-centered approach to psychiatric patients that explicitly acknowledges and addresses the central role of meaning and interpersonal factors in pharmacologic treatment.
Countertransference: What It Is and How to Use It - Elizabeth Weinberg, MD (Recorded)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 APA
  • 1.00 ASWB-ACE
  • 1.00 Contact Hours/ Participation
$0.00
This is a sixty minute presentation that will include opportunities for questions and discussion in the large group of conference attendees. This presentation addresses the scholarly literature and clinical experience relating to clinicians’ experience of countertransference, particularly in working with patients with complex treatment histories. Many clinicians struggle to understand and manage strong feelings generated in therapeutic work.
Working with the Bodily Unconscious: Somatic Narration as a Method to Anchor the Working-Through in the Body-Self - Dr. Sebastian Leikert (Recorded)
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 APA
  • 1.50 ASWB-ACE
  • 1.50 Contact Hours/ Participation
$0.00
Severely disturbed patients often show bodily symptoms relating to unrepresented states. These states result from traumatic breakdown of the patient’s ability to symbolize but also from a traumatic disorganization of the patient’s body-self. The psychoanalytic technique of interpreting the chain of free associations is in danger to overlook these encapsulated body engrams. Somatic narration describes a focused attention on the patient’s proprioception.
When the Patient Isn't Getting Better - Eric M. Plakun, MD, DLFAPA, FACPsych (Recorded)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 APA
  • 1.00 Contact Hours/ Participation
$0.00
All clinicians face the problem of working with patients whose treatments are not going well and who are not making progress. Clinicians often label these patients as "difficult" or "treatment resistant." This presentation addresses clinicians' own contributions to this experience, including the role of reductionist biomedical perspectives that do not match evolving evidence. The presentation also summarizes psychodynamic principles that may improve outcomes and the role of intermediate levels of care in treating some of these patients.  

Pages